Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Nymphaea alba Apocytochrome f (petA), partial CSB-YP728623NES1
CSB-EP728623NES1
CSB-BP728623NES1
CSB-MP728623NES1
CSB-EP728623NES1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nymphaea alba 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP728624NES
CSB-EP728624NES
CSB-BP728624NES
CSB-MP728624NES
CSB-EP728624NES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nymphaea alba Photosystem II D2 protein (psbD), partial CSB-YP728625NES1
CSB-EP728625NES1
CSB-BP728625NES1
CSB-MP728625NES1
CSB-EP728625NES1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nymphaea alba ATP synthase subunit b, chloroplastic (atpF), partial CSB-YP728626NES1
CSB-EP728626NES1
CSB-BP728626NES1
CSB-MP728626NES1
CSB-EP728626NES1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nymphaea alba Photosystem I reaction center subunit VIII (psaI), partial CSB-YP728627NES
CSB-EP728627NES
CSB-BP728627NES
CSB-MP728627NES
CSB-EP728627NES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saruma henryi Protein psbN (psbN), partial CSB-YP728628SFAI
CSB-EP728628SFAI
CSB-BP728628SFAI
CSB-MP728628SFAI
CSB-EP728628SFAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Euonymus alatus Photosystem II reaction center protein T (psbT), partial CSB-YP728629ECAE
CSB-EP728629ECAE
CSB-BP728629ECAE
CSB-MP728629ECAE
CSB-EP728629ECAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Canella winterana Photosystem II reaction center protein T (psbT), partial CSB-YP728630CGAM
CSB-EP728630CGAM
CSB-BP728630CGAM
CSB-MP728630CGAM
CSB-EP728630CGAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Stewartia pseudocamellia Photosystem II reaction center protein L (psbL), partial CSB-YP728631SFAA
CSB-EP728631SFAA
CSB-BP728631SFAA
CSB-MP728631SFAA
CSB-EP728631SFAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Houttuynia cordata Cytochrome b559 subunit beta (psbF), partial CSB-YP728632HCAP
CSB-EP728632HCAP
CSB-BP728632HCAP
CSB-MP728632HCAP
CSB-EP728632HCAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Agathis robusta Photosystem II reaction center protein L (psbL), partial CSB-YP728633AEAE
CSB-EP728633AEAE
CSB-BP728633AEAE
CSB-MP728633AEAE
CSB-EP728633AEAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesoplasma florum Ribonuclease P protein component (rnpA) CSB-YP728634MEO
CSB-EP728634MEO
CSB-BP728634MEO
CSB-MP728634MEO
CSB-EP728634MEO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesoplasma florum Deoxyribose-phosphate aldolase 2 (deoC2) CSB-YP728635MEO
CSB-EP728635MEO
CSB-BP728635MEO
CSB-MP728635MEO
CSB-EP728635MEO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesoplasma florum Elongation factor G (fusA), partial CSB-YP728636
CSB-EP728636
CSB-BP728636
CSB-MP728636
CSB-EP728636-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 5'-nucleotidase surE (surE) CSB-YP728650AAAC
CSB-EP728650AAAC
CSB-BP728650AAAC
CSB-MP728650AAAC
CSB-EP728650AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale Dephospho-CoA kinase (coaE) CSB-YP728651AAAC
CSB-EP728651AAAC
CSB-BP728651AAAC
CSB-MP728651AAAC
CSB-EP728651AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale Recombination protein RecR (recR) CSB-YP728652AAAC
CSB-EP728652AAAC
CSB-BP728652AAAC
CSB-MP728652AAAC
CSB-EP728652AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 50S ribosomal protein L33 (rpmG) CSB-YP728653AAAC
CSB-EP728653AAAC
CSB-BP728653AAAC
CSB-MP728653AAAC
CSB-EP728653AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (murE) CSB-YP728654AAAC
CSB-EP728654AAAC
CSB-BP728654AAAC
CSB-MP728654AAAC
CSB-EP728654AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 30S ribosomal protein S12 (rpsL) CSB-YP728655AAAC
CSB-EP728655AAAC
CSB-BP728655AAAC
CSB-MP728655AAAC
CSB-EP728655AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>